Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 02 April, 2010 and appeared in  Issue 515DietObesity

DNA Testing Determines which Popular Diet Will Work

New data provided some early evidence that the secret to weight loss might lie in DNA and that the best way to shed excessive pounds is to diet according to genotype....

Advertisement

Researchers are cautious, of course, but the latest study showed that when individuals were assigned to different diets -- including the low-carbohydrate Atkins diet and low-fat Ornish diet -- based on their genotype, they lost significantly more weight than those assigned to a diet unsuited to their genetics.

Dr. Christopher Gardner (Stanford University) writes, "Say you and your wife went on the Atkins diet, and you both think you followed it religiously, but you lost 13 pounds and she lost nothing and is angry because she followed the same diet. Well, she might have a different genotype. She isn't genetically predisposed to do well on a low-carbohydrate Atkins diet."

The new data are derived from a study the group previously conducted in 311 overweight women who were randomized to four popular diets: the very-low-carbohydrate Atkins diet, the low-carbohydrate Zone diet, the very-low-fat Ornish diet, and the low-fat LEARN diet. In that trial, known as the Atkins-Traditional-Ornish-Zone (A TO Z) study, women assigned to the Atkins diet had a modest benefit relative to the other diets, but overall results were disappointing in that the women, on average, lost only about 10 pounds.

"Within every diet group, though, some of the women lost more than 30 pounds and kept it off for over a year," said Gardner. "And some of the women gained more than 10 pounds. Within every diet, the range is at least 40 to 50 pounds. Between the different diets, the weight loss difference was just a few pounds, yet within the group, the difference is much larger. This is actually much more interesting than the difference between groups. How can the responses to the same diet be so different?"

With these data, the researchers were approached by Interleukin Genetics (Waltham, MA), asking them if they could obtain the DNA of the study participants. The company had previously identified three genes -- ABP2, ADRB2, and PPAR-gamma -- that could predict weight loss. These genes were shown to predict weight loss in three different studies, were biologically plausible, and were shown to have gene-diet interaction, said Gardner.

The researchers obtained DNA from 138 women and analyzed the weight loss according to genotype and diet in 133 participants. Among those participants who completed the 12-month study, researchers observed a significant interaction between diet assignment and weight loss after taking genotype pattern into consideration.

Women assigned to a genotype-appropriate diet lost 5.3% of their body weight compared with just 2.3% among those not matched to genotype (p=0.005). Within the Atkins group, for example, those appropriately assigned by genotype lost approximately 12 pounds compared with 2 pounds for those who lacked the low-carbohydrate genotype. In the Ornish group, similar reductions in weight were observed among those appropriately assigned by genotype.

Gardner said the proportion of individuals who were genetically predisposed to the low-fat or low-carbohydrate diets is roughly 50-50, so a significant number of people will fall into each category. He stressed, however, that all individuals assigned to the diet groups were instructed to make healthy, wholesome food choices.

"If they were on low-carbohydrate and high-fat, they weren't told to eat butter and whipped cream but to eat nuts, seeds, and fatty fish," he said. "If they were on the low-fat diet, they weren't told to just eat low-fat Snackwell cookies but to eat veggies, whole grains, and beans. I get worried when people just say low-carbohydrate or low-fat because they don't really understand what that means. This is what really undermines the whole public-health low-fat message."

Dr. Lawrence J. Appel (Johns Hopkins University, Baltimore, MD) said there is interest in the genetic underpinnings of nutrition, however, the environment is key in reducing obesity worldwide. "This is an area of burgeoning interest," said Appel, "but the obesity epidemic occurred pretty quickly, over the past 10 or 20 years, and our genetic pool did not change in the same period. Our obesity epidemic is an environmental problem. Given the environment, genes might influence the response to the environment, but are the genes causal? No. It's likely that the environment has a dominant impact."

Gardner agrees, that the genetic predisposition to do well on certain diets, but not on others, will not put an end to the obesity epidemic, but that the findings could be helpful in fighting the battle of the bulge. The results are retrospective and need to be interpreted cautiously, but his group is planning to conduct a larger prospective study that assigns individuals to the different diets based on genotype.

"The results don't explain the whole nutrition puzzle, but it explains a large enough chunk to be of interest," he said.

Nelson MD, Prabhakar P, Kondragunta V, et al. Genotype patterns predict weight loss success: The right diet does matter. Presented at EPI|PNAM (Cardiovascular Disease Epidemiology and Prevention and Nutrition, Physical Activity, and Metabolism) Conference March 2-5, 2010.

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 02 April, 2010 and appeared in  Issue 515DietObesity

Past five issues: Diabetes Clinical Mastery Series Issue 204 | Issue 744 | Diabetes Clinical Mastery Series Issue 203 | Issue 743 | Diabetes Clinical Mastery Series Issue 202 |

2014 Most Popular Articles:

Low-carb Diet Recommended for Type 1 and 2 Diabetes Patients
Posted August 01, 2014
New Combination of Diabetes Drugs Have Synergistic Effect
Posted August 08, 2014
FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)
Posted August 15, 2014
New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes
Posted August 08, 2014
Diabetic Neuropathy Improved with Vegan Diet
Posted August 22, 2014
CDC: 40% of American Adults Will Develop Diabetes
Posted August 22, 2014
During Prolonged Low-Intensity Exercise, Caffeine Alters Blood Glucose
Posted August 15, 2014
SGLT2 Inhibitor Empagliflozin Wins FDA OK
Posted August 08, 2014
Early Insulin Delays Diabetes But Are There Negative Consequences?
Posted August 15, 2014
Peripheral Neuropathy Associated with CV Disease and Stroke in Type 2 Diabetes Patients
Posted August 15, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
When Afrezza is available, will you prescribe it immediately or wait until it has been on the market for a while?
CME/CE of the Week
Diabetes Mellitus and the Older Adult: Prevention and Treatment
JaNellyn Hannah, MSHS, BSN, RN BC, CHES, CDE
Category: Nursing
CE Credits: 75
Search Articles On Diabetes In Control